What is Homestreet's earnings per share (EPS)?

Homestreet (HMST) reported diluted earnings per share of $1.27 for fiscal year 2025. This represents a 807.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Homestreet Financials

HMST

FY2025 annual

Revenue $49.7M +3.3% YoY

Net Income $265.7M +284.1% YoY

EPS (Diluted) $1.27 +807.1% YoY

Free Cash Flow $187.1M -34.6% YoY

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

Homestreet (HMST) reported $49.7M in revenue for fiscal year 2025, up 3.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HMST FY2025 2026-05-08

Balance-sheet funding, not reported revenue, is the dominant engine here, with cash flow driven by asset-liability shifts more than sales.

Between FY2023 and FY2025, assets expanded from $9.4B to $22.4B, a scale change far larger than the reported revenue base. Meanwhile, operating cash flow moved from $8.0M to $193.6M despite a very small reported revenue base in both recent years, which points to balance-sheet repositioning as a bigger driver of reported results than incremental top-line activity.

The balance sheet looks less dependent on long-term debt than its size suggests, with FY2025 long-term debt of only $192.0M against equity of $2.9B. But total liabilities still reached $19.5B, so the operating model is funded mainly through the broader liability base rather than a large term-debt stack.

Cash and earnings did not move together in the downturn: FY2024 posted a net loss of -$144.3M but still produced operating cash flow of $292.3M. For a reader, that is a cue to treat year-to-year cash generation here as heavily shaped by funding and asset movements, not as a clean read on recurring profitability.

Financial Health Signals

Financial Health Score 34/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Homestreet's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Growth

Capital

Efficiency

Credit Quality

Not available for Homestreet, and counted as zero in the overall score.

Stability

Piotroski F-Score Partial

3/6

Homestreet passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

0.73x

For every $1 of reported earnings, Homestreet generates $0.73 in operating cash flow ($193.6M OCF vs $265.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$49.7M

YoY+3.3%

5Y CAGR-27.7%

10Y CAGR-11.3%

Homestreet generated $49.7M in revenue in fiscal year 2025. This represents an increase of 3.3% from the prior year.

Net Income

$265.7M

YoY+284.1%

5Y CAGR+27.1%

10Y CAGR+20.5%

Homestreet reported $265.7M in net income in fiscal year 2025. This represents an increase of 284.1% from the prior year.

EPS (Diluted)

$1.27

YoY+807.1%

5Y CAGR-18.2%

10Y CAGR-4.2%

Homestreet earned $1.27 per diluted share (EPS) in fiscal year 2025. This represents an increase of 807.1% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

$187.1M

YoY-34.6%

Homestreet generated $187.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 34.6% from the prior year.

Cash & Debt

$1.0B

YoY+3.0%

5Y CAGR+77.7%

10Y CAGR+41.2%

Homestreet held $1.0B in cash against $192.0M in long-term debt as of fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity

9.3%

YoY+15.6pp

5Y CAGR-1.9pp

10Y CAGR+0.4pp

Homestreet's ROE was 9.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 15.6 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

Capital Expenditures

$6.5M

YoY+2.2%

5Y CAGR+14.6%

10Y CAGR-10.9%

Homestreet invested $6.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2.2% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

HMST Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HMST annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	N/A	$49.7M+3.3%	$48.1M-88.0%	$399.7M+31.4%	$304.3M+24.6%	$244.3M-3.1%	$252.0M-9.2%	$277.6M+10.4%	$251.5M+18.4%	$212.3M+1.3%	$209.5M+26.9%	$165.1M+48.4%	$111.3M+25.1%	$89.0M+10.3%	$80.7M+1.9%	$79.2M
SG&A Expenses	N/A	$219.3M+489.6%	$37.2M-4.1%	$38.8M+9.7%	$35.4M+12.0%	$31.6M-5.8%	$33.5M+3.0%	$32.5M-5.1%	$34.3M-9.2%	$37.8M-40.2%	$63.2M+11.2%	$56.8M+36.1%	$41.7M+3.4%	$40.4M+45.0%	$27.8M+50.6%	$18.5M
Interest Expense	N/A	$226.0M+4.4%	$216.5M-7.1%	$233.0M+228.2%	$71.0M+311.8%	$17.2M-60.2%	$43.4M-50.9%	$88.2M+43.4%	$61.5M+62.8%	$37.8M+28.1%	$29.5M+75.8%	$16.8M+32.9%	$12.6M-13.1%	$14.5M-27.2%	$19.9M-35.0%	$30.7M
Income Tax	N/A	$53.8M+703.4%	$6.7M+227.6%	-$5.2M-129.0%	$18.1M-42.0%	$31.3M+42.7%	$21.9M+174.2%	$8.0M+293.1%	$2.0M+112.0%	-$16.9M-151.8%	$32.6M+109.3%	$15.6M+41.0%	$11.1M+0.6%	$11.0M-49.0%	$21.5M+10168.2%	-$214K
Net Income	N/A	$265.7M+284.1%	-$144.3M-424.7%	-$27.5M-141.3%	$66.5M-42.4%	$115.4M+44.3%	$80.0M+356.8%	$17.5M-56.2%	$40.0M-41.9%	$68.9M+18.6%	$58.2M+40.7%	$41.3M+85.6%	$22.3M-6.5%	$23.8M-71.0%	$82.1M+409.5%	$16.1M
EPS (Diluted)	—	$1.27+807.1%	$0.14+109.6%	-$1.46-141.8%	$3.49-36.1%	$5.46+57.3%	$3.47+433.8%	$0.65-55.8%	$1.47-42.1%	$2.54+8.5%	$2.34+19.4%	$1.96+31.5%	$1.49-7.5%	$1.61-73.1%	$5.98	$2.80

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$13.0M	N/A	$12.4M-85.0%	$83.0M+622.0%	$11.5M	N/A	$12.3M-87.8%	$101.1M
SG&A Expenses	$68.5M	N/A	$54.2M+474.5%	$9.4M-8.8%	$10.3M	N/A	$9.7M-8.6%	$10.6M
Interest Expense	$62.9M	N/A	$59.2M+20.4%	$49.2M+9.0%	$45.1M	N/A	$61.1M-14.4%	$71.4M
Income Tax	$17.8M	N/A	-$10.1M-2626.3%	-$369K-102.1%	$17.7M	N/A	$15.5M+980.2%	-$1.8M
Net Income	$44.1M	N/A	$55.2M+1350.2%	-$4.4M-110.1%	$43.8M	N/A	$39.9M+740.3%	-$6.2M
EPS (Diluted)	$0.20	N/A	$0.26	-$0.23	$0.22	N/A	$0.20	-$0.33

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

HMST Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HMST annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$22.4B+35.5%	$16.5B+75.6%	$9.4B+0.3%	$9.4B+30.0%	$7.2B-0.5%	$7.2B+6.2%	$6.8B-3.3%	$7.0B+4.5%	$6.7B+8.0%	$6.2B+27.6%	$4.9B+38.5%	$3.5B+15.3%	$3.1B+16.5%	$2.6B+16.2%	$2.3B
Cash & Equivalents	$1.0B+3.0%	$999.7M+363.6%	$215.7M+196.1%	$72.8M+11.7%	$65.2M+12.3%	$58.0M+0.3%	$57.9M-0.2%	$58.0M-20.3%	$72.7M+34.8%	$53.9M+65.0%	$32.7M+7.2%	$30.5M-10.0%	$33.9M+34.1%	$25.3M-90.4%	$263.3M
Goodwill	$843.3M0.0%	$843.3M	$0-100.0%	$27.9M	N/A	N/A	$28.5M+26.3%	$22.6M0.0%	$22.6M+1.8%	$22.2M+92.5%	$11.5M-3.5%	$11.9M-1.0%	$12.1M+2745.0%	$424K	N/A
Total Liabilities	$19.5B+37.4%	$14.2B+60.2%	$8.9B+0.6%	$8.8B+35.7%	$6.5B-0.5%	$6.5B+6.3%	$6.1B-2.7%	$6.3B+4.4%	$6.0B+7.5%	$5.6B+26.8%	$4.4B+37.0%	$3.2B+15.5%	$2.8B+18.3%	$2.4B+8.7%	$2.2B
Long-Term Debt	$192.0M	$0-100.0%	$224.8M+0.2%	$224.4M+78.1%	$126.0M+0.1%	$125.8M+0.1%	$125.7M+0.1%	$125.5M+0.2%	$125.3M+0.1%	$125.1M+102.3%	$61.9M0.0%	$61.9M-4.6%	$64.8M+4.7%	$61.9M+0.1%	$61.9M
Total Equity	$2.9B+24.4%	$2.3B+3.0%	$2.2B+297.7%	$562.1M-21.4%	$715.3M-0.3%	$717.8M+5.6%	$679.7M-8.1%	$739.5M+5.0%	$704.4M+11.9%	$629.3M+35.2%	$465.3M+53.9%	$302.2M+13.7%	$265.9M+0.8%	$263.8M+205.3%	$86.4M
Retained Earnings	$456.7M+90.7%	$239.5M-39.4%	$395.4M-9.1%	$435.1M-2.1%	$444.3M+10.0%	$403.9M+7.8%	$374.7M-9.1%	$412.0M+10.8%	$372.0M+22.8%	$303.0M+23.7%	$244.9M+20.3%	$203.6M+11.3%	$182.9M+11.6%	$163.9M+100.5%	$81.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$21.4B-4.3%	$22.4B-1.6%	$22.7B+198.4%	$7.6B-2.5%	$7.8B-52.7%	$16.5B+79.2%	$9.2B-0.7%	$9.3B
Cash & Equivalents	$483.5M-53.1%	$1.0B-28.6%	$1.4B+617.4%	$201.1M-20.3%	$252.2M-74.8%	$999.7M+385.6%	$205.9M-5.9%	$218.7M
Goodwill	$843.3M0.0%	$843.3M0.0%	$843.3M	N/A	N/A	$843.3M	N/A	N/A
Total Liabilities	$18.6B-4.6%	$19.5B-2.2%	$19.9B+283.9%	$5.2B-4.4%	$5.4B-61.7%	$14.2B+63.8%	$8.7B-0.9%	$8.7B
Long-Term Debt	$128.8M-32.9%	$192.0M+1.0%	$190.1M-15.6%	$225.3M0.0%	$225.2M	$0	$0-100.0%	$224.9M
Total Equity	$2.8B-2.5%	$2.9B+3.2%	$2.8B+14.8%	$2.4B+1.8%	$2.4B+3.1%	$2.3B+0.1%	$2.3B+2.5%	$2.2B
Retained Earnings	$407.9M-10.7%	$456.7M+19.9%	$381.0M+57.3%	$242.1M-1.8%	$246.5M+2.9%	$239.5M-36.0%	$374.3M-1.9%	$381.6M

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities.

HMST Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HMST annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$206.4M	$193.6M-33.8%	$292.3M+3542.4%	$8.0M-96.3%	$218.3M+26.2%	$173.0M+777.4%	-$25.5M-109.9%	$258.8M-9.5%	$286.0M+79.5%	$159.3M+455.7%	-$44.8M-639.0%	$8.3M+102.4%	-$348.6M-214.7%	$304.0M+177.6%	-$391.9M-536.8%	$89.7M
Capital Expenditures	$8.7M	$6.5M+2.2%	$6.4M+67.2%	$3.8M-43.8%	$6.8M+130.7%	$2.9M-10.8%	$3.3M+46.1%	$2.3M-76.8%	$9.7M-77.0%	$42.3M+72.7%	$24.5M+19.1%	$20.6M+3.3%	$19.9M-12.9%	$22.8M+100.3%	$11.4M+548.6%	$1.8M
Free Cash Flow	$197.1M	$187.1M-34.6%	$285.9M+6685.9%	$4.2M-98.0%	$211.5M+24.4%	$170.1M+689.7%	-$28.8M-111.2%	$256.6M-7.1%	$276.3M+136.1%	$117.0M+268.9%	-$69.3M-465.6%	-$12.2M+96.7%	-$368.5M-231.1%	$281.2M+169.7%	-$403.3M-558.5%	$88.0M
Investing Cash Flow	$2.2B	$1.5B+224.6%	$476.2M-1.6%	$484.0M+118.2%	-$2.7B-2012.5%	-$125.6M+46.0%	-$232.6M-317.4%	$107.0M+119.0%	-$564.1M-1.4%	-$556.2M+32.1%	-$819.3M-95.8%	-$418.3M-396.6%	-$84.2M+81.7%	-$459.9M-347.1%	-$102.9M-131.0%	$331.9M
Financing Cash Flow	-$2.7B	-$1.7B-39.4%	-$1.2B-251.1%	-$349.2M-114.3%	$2.4B+6173.4%	-$40.2M-115.6%	$258.3M+170.5%	-$366.6M-239.5%	$262.7M-36.6%	$414.4M-53.2%	$885.3M+114.8%	$412.2M-4.0%	$429.5M+161.1%	$164.5M-35.9%	$256.7M+211.2%	-$230.9M
Dividends Paid	N/A	$48.6M-48.9%	$95.0M+671.2%	$12.3M-54.1%	$26.8M+25.8%	$21.3M+53.9%	$13.9M	$0	$0	N/A	$0	$0-100.0%	$1.6M	$0	$0	N/A
Share Buybacks	N/A	N/A	N/A	$0-100.0%	$75.0M-10.9%	$84.2M+45.1%	$58.0M-41.1%	$98.5M	$0-100.0%	$45K	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$11.4M-90.0%	$113.9M+1.8%	$112.0M+462.9%	-$30.9M-2045.5%	-$1.4M-101.9%	$74.9M-69.7%	$247.0M+1235.4%	-$21.8M
Capital Expenditures	$2.6M-24.4%	$3.5M+21.4%	$2.9M+725.9%	-$348K-30.0%	$497K-79.8%	$2.5M+1.0%	-$2.4M+744.3%	$289K
Free Cash Flow	$8.8M-92.1%	$110.4M+1.2%	$109.1M+449.6%	-$31.2M-1512.4%	-$1.9M-102.7%	$72.4M-70.4%	$244.5M+1209.4%	-$22.0M
Investing Cash Flow	$381.8M+857.3%	-$50.4M-104.0%	$1.3B+113.5%	$587.0M+340.2%	-$244.4M-207.8%	-$79.4M-118.4%	$432.6M+397.2%	$87.0M
Financing Cash Flow	-$939.7M-97.3%	-$476.2M+33.6%	-$716.9M-28.0%	-$560.3M-1361.2%	$44.4M+125.5%	-$174.0M+81.9%	-$962.0M-476.6%	-$166.8M
Dividends Paid	$92.6M+90.6%	$48.6M	N/A	N/A	$0	$0-100.0%	$95.0M	$0

HMST Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HMST annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	534.4%	-299.9%	-6.9%-28.7pp	21.9%-25.4pp	47.3%+15.5pp	31.7%+25.4pp	6.3%-9.6pp	15.9%-16.5pp	32.5%+4.7pp	27.8%+2.7pp	25.0%+5.0pp	20.0%-6.8pp	26.8%	101.8%	20.3%
Return on Equity	9.3%+15.6pp	-6.3%-5.0pp	-1.2%-13.1pp	11.8%-4.3pp	16.1%+5.0pp	11.1%+8.6pp	2.6%-2.8pp	5.4%-4.4pp	9.8%+0.6pp	9.2%+0.4pp	8.9%+1.5pp	7.4%-1.6pp	8.9%-22.2pp	31.1%+12.5pp	18.6%
Return on Assets	1.2%+2.1pp	-0.9%-0.6pp	-0.3%-1.0pp	0.7%-0.9pp	1.6%+0.5pp	1.1%+0.9pp	0.3%-0.3pp	0.6%-0.5pp	1.0%+0.1pp	0.9%+0.1pp	0.8%+0.2pp	0.6%-0.1pp	0.8%-2.3pp	3.1%+2.4pp	0.7%
Debt-to-Equity	0.07+0.1x	0.00-0.1x	0.10-0.3x	0.40+0.2x	0.180.0x	0.180.0x	0.180.0x	0.170.0x	0.180.0x	0.20+0.1x	0.13-0.1x	0.200.0x	0.240.0x	0.23-0.5x	0.72
FCF Margin	376.2%	594.0%	1.1%-68.5pp	69.5%-0.1pp	69.6%+81.1pp	-11.5%-103.9pp	92.4%	109.9%	55.1%+88.2pp	-33.1%-25.6pp	-7.4%	-331.1%	316.0%	-499.8%	111.1%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Net Margin	338.7%	N/A	444.2%	-5.3%	380.8%	N/A	325.0%	-6.2%
Return on Equity	1.6%	N/A	2.0%+2.2pp	-0.2%-2.0pp	1.8%	N/A	1.7%+2.0pp	-0.3%
Return on Assets	0.2%	N/A	0.2%+0.3pp	-0.1%-0.6pp	0.6%	N/A	0.4%+0.5pp	-0.1%
Debt-to-Equity	0.050.0x	0.070.0x	0.070.0x	0.090.0x	0.09+0.1x	0.000.0x	0.00-0.1x	0.10
FCF Margin	67.3%	N/A	878.5%	-37.6%-20.8pp	-16.8%	N/A	1989.2%	-21.8%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.

Similar Companies

Timberland Bncp TSBK

$357.8M

Fidelity Dam FDBC

$315.1M

Primis Financial Corp FRST

$400.3M

Waterstone Finl Inc Md WSBF

$376.8M

Northeast Cmnty Bancorp Inc NECB

$362.7M

Where Homestreet Ranks

Frequently Asked Questions

What is Homestreet's annual revenue?

Homestreet (HMST) reported $49.7M in total revenue for fiscal year 2025. This represents a 3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Homestreet's revenue growing?

Homestreet (HMST) revenue grew by 3.3% year-over-year, from $48.1M to $49.7M in fiscal year 2025.

Is Homestreet profitable?

Yes, Homestreet (HMST) reported a net income of $265.7M in fiscal year 2025.

How much debt does Homestreet have?

As of fiscal year 2025, Homestreet (HMST) had $1.0B in cash and equivalents against $192.0M in long-term debt.

What is Homestreet's return on equity (ROE)?

Homestreet (HMST) has a return on equity of 9.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Homestreet's free cash flow?

Homestreet (HMST) generated $187.1M in free cash flow during fiscal year 2025. This represents a -34.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Homestreet's operating cash flow?

Homestreet (HMST) generated $193.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Homestreet's total assets?

Homestreet (HMST) had $22.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Homestreet's capital expenditures?

Homestreet (HMST) invested $6.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is Homestreet's debt-to-equity ratio?

Homestreet (HMST) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Homestreet's return on assets (ROA)?

Homestreet (HMST) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Homestreet's Piotroski F-Score?

Homestreet (HMST) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Homestreet's earnings high quality?

Homestreet (HMST) has an earnings quality ratio of 0.73x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Homestreet?

Homestreet (HMST) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.